113 related articles for article (PubMed ID: 915292)
1. Potentiation of the immune response to influenza virus subunit vaccines.
Webster RG; Glezen WP; Hannoun C; Laver WG
J Immunol; 1977 Dec; 119(6):2073-7. PubMed ID: 915292
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the immune response to influenza virus subunit vaccines.
Webster RG; Glezen WP; Kasel JA; Laver WG
Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
[TBL] [Abstract][Full Text] [Related]
3. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
[TBL] [Abstract][Full Text] [Related]
4. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
[TBL] [Abstract][Full Text] [Related]
5. The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.
Crawford CR; Jennings R; Bradford N; Potter CW
Clin Exp Immunol; 1982 Jun; 48(3):739-46. PubMed ID: 6811173
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
7. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
[TBL] [Abstract][Full Text] [Related]
8. [Potentiation of immune responses to influenza split virus vaccine by synthetic 6-O-acyl-muramylpeptides].
Okunaga T
Osaka Daigaku Shigaku Zasshi; 1980 Jun; 25(1):29-52. PubMed ID: 6935421
[No Abstract] [Full Text] [Related]
9. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
12. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.
Del Giudice G; Hilbert AK; Bugarini R; Minutello A; Popova O; Toneatto D; Schoendorf I; Borkowski A; Rappuoli R; Podda A
Vaccine; 2006 Apr; 24(16):3063-5. PubMed ID: 16464520
[TBL] [Abstract][Full Text] [Related]
13. Impact of influenza vaccine formulation with a detailed analysis of the cytokine response.
Szyszko E; Brokstad K; Cox RJ; Hovden AO; Madhun A; Haaheim LR
Scand J Immunol; 2006 Nov; 64(5):467-75. PubMed ID: 17032238
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
[TBL] [Abstract][Full Text] [Related]
15. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
18. Effect of priming infection on serologic response to whole and subunit influenza virus vaccines in animals.
McLaren C; Verbonitz MW; Daniel S; Grubbs GE; Ennis FA
J Infect Dis; 1977 Dec; 136 Suppl():S706-11. PubMed ID: 606796
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
20. Assessment of resistance to influenza virus infection in animal models.
Potter CW; McLaren C; Jennings R
Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
